|
A recent case study on the abuse potential of Mirogabalin, a novel α2δ ligand, and our tips on how to conduct a successful Human Abuse Potential (HAP) study.
|
|
View our latest assay list and register for our upcoming bioanalytical webinars.
|
|
Get on-demand viewing and access to the Q&A session of our webinar on examining changes in cognition in clinical pharmacology studies.
|
|
View our recently published articles in Pharma Tech Outlook and Clinical Trials Insight magazines to see what differentiates Altasciences from other CROs and the techniques we use to enhance safety in clinical trials.
|
|
Altasciences to acquire a USA-based preclinical contract research organization, adding comprehensive safety testing services to its current full-service clinical and bioanalytical offerings. Check out all our latest news releases!
|
|
See the full lineup of events we will be attending and don’t miss our scientific presentations at the upcoming AAPS PharmSci 360 meeting on November 4-7 in Washington, DC.
|
|
|
| |
